Growth factor signaling components up-regulated in hepatocellular carcinoma (HCC).
| PAG Title | Growth factor signaling components up-regulated in hepatocellular carcinoma (HCC). |
| PAG ID | MAX000265 |
| Type | A |
| Source Link |  MSigDB |
| Publication Reference | NA |
| PAG Description | Dysregulation of pleiotropic growth factors, receptors and their downstream signaling pathway components represent a central protumorigenic principle in human hepatocarcinogenesis. Especially the Insulin-like Growth Factor/IGF-1 receptor (IGF/IGF-1R), Hepatocyte Growth Factor (HGF/MET), Wingless (Wnt/beta-catenin/FZD), Transforming Growth Factor alpha/Epidermal Growth Factor receptor (TGFalpha/EGFR) and Transforming Growth Factor beta (TGFbeta/TbetaR) pathways contribute to proliferation, antiapoptosis and invasive behavior of tumor cells. This review focuses on the relevant alterations in these pathways identified in human human hepatocellular carcinomas (HCCs). Resultant functional effects are modulated by multiple cross-talks between the different signaling pathways and additional tumor-relevant factors, such as cyclooxygenase-2 and p53. Several specific strategies are currently under development such as receptor kinase inhibitors, neutralizing antibodies and antagonistic proteins, which may improve the systemic treatment of human HCCs. |
| Species | Homo sapiens |
| Quality Metric Scores | nCoCo Score: 1,235 |
| Information Content | Rich |
| Other IDs | M18219 |
| Base PAG ID | MAX000265 |
| Human Phenotyte Annotation | |
| Curator | PAGER curation team |
| Curator Contact | PAGER-contact@googlegroups.com |
">
Something else? Please send us an email!